Evidence map›Paper›PMID 24701239›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2014

Seoritae extract reduces prostate weight and suppresses prostate cell proliferation in a rat model of benign prostate hyperplasia.

Hoon Jang, Woong-Jin Bae, Seung-Mo Yuk, Dong-Seok Han, U-Syn Ha, Seong-Yeon Hwang, Shin-Hee Yoon, Sae-Woong Kim, Chang-Hee Han

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Inhibition of αNutrients · 2022
    Article
  2. Review
  3. Review
  4. The Effect ofEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  5. Article
  6. Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2016
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hoon JangDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.ORCID 0000-0003-0534-549X
Woong-Jin BaeDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
Seung-Mo YukDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
Dong-Seok HanDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
U-Syn HaDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
Seong-Yeon HwangKorea Bio Medical Science Institute, Prime Tower 1st Floor Sinmunno 2-ga, Jongno-gu, Seoul 110-062, Republic of Korea.
Shin-Hee YoonThe Catholic Agro-Medical Center, The Catholic University of Korea, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
Sae-Woong KimDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea.
Chang-Hee HanDepartment of Urology, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital, 222 Banpo-daero, Seocho-Gu, Seoul 137-701, Republic of Korea ; The Catholic University of Korea, Uijeongbu, St. Mary's Hospital 271, Cheon Bo-Ro, Uijeongbu-Si, Gyeonggi-Do 480-717, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seoritae is a type of black soybean that is known to have health-promoting effects due to its high isoflavone and anthocyanin contents. We evaluated whether Seoritae extract (SE) had beneficial effects on the reduction of prostate weight in a rat model of benign prostatic hyperplasia (BPH). BPH was induced by intramuscular injections of testosterone enanthate once a week for 5 weeks in Sprague-Dawley rats, and rats were treated with or without daily oral doses of SE during BPH induction. After 5 weeks, the oxidative stress (superoxide dismutase and 8-hydroxy-2-deoxyguanosine), apoptosis (caspase-3), and activity of 5-alpha reductase were evaluated in the serum and prostate. The SE treatment group showed a significant decrease in prostate weight, oxidative stress, apoptosis, and 5-alpha reductase activity compared to the nontreated BPH group. These results show that SE is effective in decreasing the weight and proliferation of the prostate, and suggest that SE may be an effective treatment for BPH.

Identifiers

PMID24701239
PMCPMC3950473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.